Globus Medical(GMED) - 2024 Q4 - Annual Report
Globus Medical(GMED)2025-02-20 22:05UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Title of each class Trading Symbol(s) Name of exchange on which registered Class A Common Stock, par value $.001 per share GMED New York Stock E ...